Shaily Engineering Q2 Revenue Rises To ₹320 Crore From ₹257 Crore YoY

Market snapshot: Shaily Engineering Plastics reported its Q2 financial results, registering revenue of ₹320 crore compared to ₹257 crore in the corresponding quarter of the previous year. The performance reflects a year-on-year revenue expansion across core precision plastics and medical packaging businesses.

Data Snapshot

• Q2 revenue reached ₹320 crore compared to ₹257 crore in the same period last year.

What's Changed

• Top-line growth of ≈24.51% YoY (derived: ₹320 crore vs ₹257 crore).

Key Takeaways

• Q2 revenue expanded to ₹320 crore from ₹257 crore in the prior-year quarter.
• Year-on-year growth demonstrates sustained order execution in high-precision healthcare and industrial packaging.
• Scalability in contract manufacturing and specialized medical device components supports ongoing top-line trajectory.

SAHI Perspective

The revenue growth to ₹320 crore highlights Shaily's strengthening positioning in value-added healthcare plastics and pen injectors. Expanding scale in high-margin medical applications helps buffer operational performance against raw material price variations in commodity polymers.

Market Implications

Steady top-line expansion enhances operational leverage, helping improve fixed-cost absorption across manufacturing units over coming quarters.

Trading Signals

Market Bias: Bullish

Bias is supported by Q2 revenue rising to ₹320 crore from ₹257 crore YoY (≈24.51% growth), confirming healthy top-line expansion.

Overweight: Precision Plastics, Healthcare Devices & Packaging

Trigger Factors:

• Full margin details in complete financial results filing
• Commercial volume ramp-up on contract manufacturing orders
• Polymer raw material price trends

Time Horizon: Near-term (0-3 months)

Industry Context

India's precision plastic moulding and medical device contract manufacturing sectors continue to gain momentum, driven by global supply chain diversification and demand for drug delivery devices.

Key Risks to Watch

• Fluctuations in polymer raw material prices linked to crude oil
• Global freight and container logistics volatility affecting export shipments
• Customer concentration in major healthcare delivery programs

Recent Developments

Shaily Engineering Plastics secured a commercial supply contract valued at ₹423 crore from a large domestic pharmaceutical company for pen injectors over a four-year period.

Closing Insight

With Q2 revenue reaching ₹320 crore, Shaily Engineering continues to demonstrate solid revenue execution driven by its healthcare and precision moulding portfolio.

High Performance Trading with SAHI.